SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-21-026971
Filing Date
2021-05-17
Accepted
2021-05-17 16:01:44
Documents
55
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0321_virpaxpharma.htm 10-Q 422016
2 CERTIFICATION f10q0321ex31-1_virpaxpharma.htm EX-31.1 14362
3 CERTIFICATION f10q0321ex31-2_virpaxpharma.htm EX-31.2 14449
4 CERTIFICATION f10q0321ex32-1_virpaxpharma.htm EX-32.1 8423
  Complete submission text file 0001213900-21-026971.txt   2787756

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE vrpx-20210331.xml EX-101.INS 345241
6 XBRL SCHEMA FILE vrpx-20210331.xsd EX-101.SCH 41417
7 XBRL CALCULATION FILE vrpx-20210331_cal.xml EX-101.CAL 23085
8 XBRL DEFINITION FILE vrpx-20210331_def.xml EX-101.DEF 179652
9 XBRL LABEL FILE vrpx-20210331_lab.xml EX-101.LAB 353837
10 XBRL PRESENTATION FILE vrpx-20210331_pre.xml EX-101.PRE 190232
Mailing Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380
Business Address 1554 PAOLI PIKE #279 WEST CHESTER PA 19380 484-875-3195
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40064 | Film No.: 21930209
SIC: 2834 Pharmaceutical Preparations